Effects of continuous flow left ventricular assist device support on microvascular endothelial function

Area of Science:

• Cardiology
• Vascular Biology
• Biomedical Engineering

Background:

• Heart failure (HF) significantly impacts microvascular endothelial function.
• Continuous flow left ventricular assist devices (CF-LVADs) are crucial for end-stage HF management.
• The specific effects of CF-LVADs on microvascular endothelial function remain largely uncharacterized.

Purpose of the Study:

• To investigate the impact of CF-LVAD support on microvascular endothelial function in NYHA class IV HF patients.
• To compare endothelial function in HF patients before and after CF-LVAD implantation.
• To establish a baseline for future research on long-term CF-LVAD effects.

Main Methods:

• Assessed microvascular endothelial function using beat-to-beat plethysmography during reactive hyperemia.
• Evaluated three groups: NYHA class IV HF patients pre-CF-LVAD (HF), NYHA class IV HF patients 1-4 months post-CF-LVAD (CF-LVAD), and age-matched healthy controls.
• Measured systolic and diastolic blood pressure and the reactive hyperemic index (RHI).

Main Results:

• No significant differences in age, weight, or height were observed among the groups.
• Systolic blood pressure was lower in HF and CF-LVAD groups compared to controls.
• Diastolic blood pressure was significantly lower in the HF group than in control and CF-LVAD groups.
• The reactive hyperemic index (RHI), indicating endothelial function, was significantly higher in controls than in both HF and CF-LVAD groups.
• No significant difference in RHI was found between the HF and CF-LVAD groups.

Conclusions:

• One to four months of CF-LVAD support does not adversely affect microvascular endothelial function in NYHA class IV HF patients.
• CF-LVAD support within this timeframe does not lead to significant improvements in vascular function of resistance vessels.
• Further studies are needed to evaluate the long-term effects of CF-LVADs on endothelial function.